Background:
In response to noxious stimulation, pupillary dilation reflex (PDR) occurs even in anaesthetized patients. The aim of the study was to evaluate the ability of pupillometry with an automated increasing stimulus intensity to monitor intraoperative opioid administration.
Methods:
Thirty-four patients undergoing elective surgery were enrolled. Induction by propofol anaesthesia was increased progressively until the sedation depth criteria (SeD) were attained. Subsequently, a first dynamic pupil measurement was performed by applying standardized nociceptive stimulation (SNS). A second PDR evaluation was performed when remifentanil reached a target effect-site concentration. Automated infrared pupillometry was used to determine PDR during nociceptive stimulations generating a unique pupillary pain index (PPI). Vital signs were measured.
Results: After opioid administration, anaesthetized patients required a higher stimulation intensity (57.43 mA vs 32.29 mA, P < .0005). Pupil variation in response to the nociceptive stimulations was significantly reduced after opioid administration (8 mm vs 28 mm, P < .0005). The PPI score decreased after analgesic treatment (8 vs 2, P < .0005), corresponding to a 30% decrease. The elicitation of PDR by nociceptive stimulation was performed without changes in vital signs before (HR 76 vs 74/min, P = .09; SBP 123 vs 113 mm Hg, P = .001) and after opioid administration (HR 63 vs 62/min, P = .4; SBP 98.66 vs 93.77 mm Hg, P = .032).
Conclusions:
During propofol anaesthesia, pupillometry with the possibility of lowintensity standardized noxious stimulation via PPI protocol can be used for PDR assessment in response to remifentanil administration.
| INTRODUCTION
Despite the availability of numerous innovative technologies, 1,2 analgesia assessment in anaesthetized patients is not integrated in routine perioperative patient care. 3 Patients are frequently unable to communicate as a result of sedative administration. For evaluation of a nociceptive/anti-nociceptive balance and subsequent optimal analgesic (mostly opioids) treatment, anaesthesiologists still use non-specific changes in heart rate (HR) or blood pressure (BP) in combination with the locomotor response as a surrogate for nociception. 4 It has been recently demonstrated that PDR can be elicited under general anaesthesia with an automated generated electrical stimulation protocol with increasing intensity. 5, 6 These study results were consistent with findings from previous studies with a single (high) tetanic stimulation for PDR elicitation in non-communicative patients. [7] [8] [9] Given the development of pupilometers with an integrated automated pupil tracking system, 10 PDR can be used during surgical procedures in the operation room for nociceptive state evaluation. [11] [12] [13] with hypoxia and/or hypercarbia. 15 To date, little is known about PDR evaluation after multiple increasing standardized noxious stimulations starting at 10 mA generated by an inbuilt PPI protocol (PPI, pupillary pain index) as an alternative for high tetanic stimulation. Although significant research is devoted to nociceptive monitoring, less attention has been paid to different techniques for PDR elicitation.
The aim of this study was to evaluate the PPI stimulation protocol for PDR measurement before and after opioid administration in adult patients undergoing general anaesthesia.
| ME TH ODS

| Study design
This single-centre interventional cohort study was performed in accordance with the ethical standards of ICH-GCP and the Declara- antagonists or anti-emetics were defined as exclusion criteria. The patients did not receive premedication.
| Definition of outcome parameters
The primary outcome was the difference in stimulation intensity necessary for pupil dilation of >13% before and after opioid (ie, remifentanil) administration, as defined by the inbuilt PPI stimulation protocol. Secondary outcome measurements were changes in vital signs before and after standardized nociceptive stimulation. HR and BP were recorded before and immediately after stimulation.
| Study protocol
The enrolled subjects underwent 2 consecutive, by convention left, pupil measurements under general anaesthesia. Pupil assessments were executed before surgery. Anaesthesia was induced with propofol (propolipid 1%) by target controlled infusion (TCI; Marsh-model;
injectomat TIVA Agilia, Fresenius Kabi, Germany), 16, 17 and the target effect-site concentration (Ce) was progressively increased until loss of consciousness (LOC). The sedation depth (SeD) ranged from 40 to 50 on the sedation depth brain monitor NeuroSense â (NeuroWave Systems Inc., Cleveland, OH). Thereafter, the first PDR measurement was performed. Consequently, the subjects received remifentanil by continuous infusion up to Ce 5 ng mL À1 using the pharmacokinetics of Minto. 18 Manually assisted ventilation using a facemask with 100% oxygen was initiated as soon as the subjects became apnoeic.
Then, 0.6 mg kg À1 rocuronium was administered to facilitate orotracheal intubation when considered necessary by the attending anaesthesiologist. No deep neuromuscular block was used during surgery. 
| Standardized nociceptive stimulation and measurements of pupil characteristics
For PDR measurement, we used the CE-approved NeuroLight AlgiScan â (IDMed, Marseille, France) pupillometre using infrared F I G U R E 1 Summary of study timeline. TCA, target controlled analgesia; SeD, sedation depth; PPI, pupillary pain index; Ce, effectsite concentration
Editorial Comment Acute pain and analgesics can influence autonomic pupillary responses. This study assesses an application for measuring the degree of analgesia with pupillometry by using standardized noxious stimuli during general anaesthesia. Further research is needed in order to assess the possible usefulness of this method in clinical situations.
video recording to allow quantitative pupil size assessment during steady-state anaesthesia. For nociceptive stimulation, 2 Ag-AgCl electrodes with low impedance were optimally placed at the skin area innervated by the median nerve. Constant current stimulations were generated during pupil measurement, and the voltage was automatically increased according to the resistance. The voltage is limited to a maximum of 300 V. Therefore, for a current fixed at 60 mA, the maximum acceptable resistance is 5 kΩ. The time to reach the medication plateau level and therefore pupil analyses were recorded.
The upper eyelid of the measured eye was opened during pupil assessment. A rubber cup was placed on the orbit ensured optimal device position, pupil-camera distance and environmental darkness.
Direct contact with the cornea never occurred. The contralateral eye was closed, reducing the effect of the consensual light response.
| Pupillary pain index protocol
Via the touch screen display, the PPI-modus was selected for dynamic pupil measurement. This inbuilt measurement protocol generates an automatic electrical stimulation pattern. The operating principle is the application of a standardized noxious stimulation (from 10 to 60 mA by incremental steps of 10 mA, with a duration of 1 second, and pulse width of 200 ls) starting at low stimulation intensity in increasing steps until a pupillary dilation of >13% is achieved ([maximal diameter À minimal diameter]/maximal diameter 9 100). When the defined criteria are achieved, stimulation is automatically stopped, reducing unnecessary high stimulation. Then, the PPI score is determined ( Table 1 ). The generated PPI score is calculated depending on the necessary stimulation intensity to provoke a pupil dilation of >13% (ie, inbuilt cut-off criteria) and pupil reflex amplitude. One point is added to the 9-level PPI score if the dilation of the pupil is >20% despite a halt of stimulation at 13%. The measurable pupil size (diameter) ranges between 0.1 and 10 mm. Furthermore, the baseline (minimum) and maximum amplitude are recorded. Depending on the necessary stimulation intensity, the pupil measurement duration is between 2 and 16 seconds.
| Statistical analysis
From an earlier pilot study, data were available to make assumptions for the sample size calculation, which included 34 subjects (a = .05, 1Àb = .9, difference to detect = 10 mA). 6 Data analyses were screened for quality by a statistical department member.
Pupil characteristics were based on median and quartiles. Heart rate and blood pressure variables were reported as means AE standard deviation (SD). Pupil size variation was tested using non-parametric analysis methods, as a normal distribution is unlikely in the study population. Mean stimulation intensity and sedation depth before and after opioid administration were compared using the unpaired Wilcoxon tests. These tests were also employed for comparisons of pupil diameter, HR, and SBP before and after nociceptive stimulation. Statistical analyses were performed with SPSS Statistics software, version 20.0 for Mac (IBM Corp., Armonk, NY, USA).
Statistical significance was considered as P < .05.
| RESULTS
Thirty-four patients were enrolled in the study. Five subjects were found to require maximal stimulation intensity for the primary measurement (ie, 60 mA). Nevertheless, the PPI varied in this subgroup from 4 to 2. In the enrolled patients, the male/female ratio was 9/ analyses. The pupil characteristics are presented in Table 2 . Differences in the baseline pupil measurements, stimulation intensity and PPI scores are presented in Figure 2 . The BP and HR decreased from the awake state to the LOC (Table 3 ).
In the absence of noxious stimulation, the pupil size (baseline diameter) decreased from the LOC to the point that remifentanil Ce 5 ng mL À1 was achieved. The sedation level (SeD) was comparable for both pupil assessments. The pupil dilation response to the builtin noxious stimulation PPI protocol decreased from LOC to remifentanil Ce 5 ng mL
À1
, ie, stimulation intensity increased significantly If the pupil dilation is over 20% during stimulation, the PPI score is increased with one point.
after opioid administration. At the second PDR evaluation, the pupil variation (amplitude response after SNS) was remarkably reduced without frequent pupil "overshooting" (dilation of >13%). After opioid administration, maximal stimulation was necessary in 30 subjects to obtain a pupillary dilation of at least 13%. The PPI score, which was automatically coupled by the pupillometre to stimulation Propofol, lidocaine and neuromuscular blocking agents do not affect pupil reactivity in contrast to modern inhalation anaesthetics, such as sevoflurane and suprane, and nociceptive stimulation still induces mydriasis under general anaesthesia. 21, 22 Opioids mediate pupil diameter under general anaesthesia by E.W. nucleus disinhibition, resulting in miosis, and depress PDR in a dose-dependent manner. 23 To date, the mechanisms of blocking this pupil reflex are not completely understood.
Larson et al 11 demonstrated the superiority of pupillometry for assessing nociception above vital signs during isoflurane and propofol anaesthesia. More recent research from Barvais and colleagues confirms those findings in volunteers during propofol anaesthesia.
PDR upon a single painful tetanic stimulation was a better indicator for remifentanil titration than a haemodynamic response or BIS measurements during propofol TCI in healthy individuals. 23 In our study methodology, we used propofol TCI and remifentanil via continuous infusion, which is the most common technique for total intravenous anaesthesia (TIVA).
Sedation depth monitoring equipment is being used more fre- have been suggested. 30, 31 To date, no gender difference in PDR under general anaesthesia has been demonstrated. Second, no conclusions can be made regarding the assessment of the nociception level given that only 2 dosages of remifentanil are allowed. Moreover, the majority of the subjects had a PPI score of 2, suggesting the possibility of opioid dose reduction.
To date, whether a titratable analgesia level is assessable using 
